Key facts
- CanSino Biologics (HKG: 06185) is a other based in Tianjin, China.
About CanSino Biologics (HKG: 06185)
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing and commercialization of vaccine products for human use. These include products such as pneumococcal polysaccharide and conjugate vaccines as well as a DTcP-based combo and other items. At the same time, the group is also dedicated to the development of new vaccine-like recombinant adenovirus vector-based tuberculosis vaccines and a recombinant protein-based pneumococcal vaccine. Geographically, the activities are carried out through China.
Free account
See more of the book
- ·Watchlist + alerts for CanSino Biologics (HKG: 06185)'s activity
Create free account
No card required
Portfolio
Portfolio — not yet on record
No portfolio companies for CanSino Biologics (HKG: 06185) are on record yet. Positions surface from round participations, filings, and coverage.
Pro members can request priority coverage with a 48-hour turnaround.